JPH0327535B2 - - Google Patents
Info
- Publication number
- JPH0327535B2 JPH0327535B2 JP19322185A JP19322185A JPH0327535B2 JP H0327535 B2 JPH0327535 B2 JP H0327535B2 JP 19322185 A JP19322185 A JP 19322185A JP 19322185 A JP19322185 A JP 19322185A JP H0327535 B2 JPH0327535 B2 JP H0327535B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- soft capsule
- active vitamin
- hydroxycholecalciferol
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000007901 soft capsule Substances 0.000 claims description 23
- 235000012730 carminic acid Nutrition 0.000 claims description 16
- 239000003086 colorant Substances 0.000 claims description 15
- 239000004106 carminic acid Substances 0.000 claims description 14
- DGQLVPJVXFOQEV-NGOCYOHBSA-N carminic acid Chemical compound OC1=C2C(=O)C=3C(C)=C(C(O)=O)C(O)=CC=3C(=O)C2=C(O)C(O)=C1[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DGQLVPJVXFOQEV-NGOCYOHBSA-N 0.000 claims description 14
- 229940114118 carminic acid Drugs 0.000 claims description 14
- 239000000049 pigment Substances 0.000 claims description 13
- 244000299461 Theobroma cacao Species 0.000 claims description 10
- 229930003316 Vitamin D Natural products 0.000 claims description 10
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 10
- 239000011710 vitamin D Substances 0.000 claims description 10
- 235000019166 vitamin D Nutrition 0.000 claims description 10
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 10
- 229940046008 vitamin d Drugs 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 9
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 claims description 7
- 229940117893 apigenin Drugs 0.000 claims description 7
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 claims description 7
- 235000008714 apigenin Nutrition 0.000 claims description 7
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 claims description 6
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 claims description 6
- 235000001046 cacaotero Nutrition 0.000 claims description 6
- NEZONWMXZKDMKF-JTQLQIEISA-N Alkannin Chemical compound C1=CC(O)=C2C(=O)C([C@@H](O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-JTQLQIEISA-N 0.000 claims description 4
- 241001071917 Lithospermum Species 0.000 claims description 4
- UNNKKUDWEASWDN-UHFFFAOYSA-N alkannin Natural products CC(=CCC(O)c1cc(O)c2C(=O)C=CC(=O)c2c1O)C UNNKKUDWEASWDN-UHFFFAOYSA-N 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- OFHCOWSQAMBJIW-AVJTYSNKSA-N alfacalcidol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C OFHCOWSQAMBJIW-AVJTYSNKSA-N 0.000 description 8
- 229960002535 alfacalcidol Drugs 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 5
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 4
- 235000009470 Theobroma cacao Nutrition 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 235000013736 caramel Nutrition 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- BJYLYJCXYAMOFT-RRXOBRNQSA-N (1r,3s,5z)-5-[(2e)-2-[(1r,3as,7ar)-1-[(2r)-5-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCC(O)C(C)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C BJYLYJCXYAMOFT-RRXOBRNQSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000011612 calcitriol Substances 0.000 description 3
- GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 235000020964 calcitriol Nutrition 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000010685 fatty oil Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000001054 red pigment Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- BWFQMABKLLTETH-YGQRWWDYSA-N (1S)-1,25-dihydroxy-24-oxocalciol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCC(=O)C(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C BWFQMABKLLTETH-YGQRWWDYSA-N 0.000 description 1
- SNOXQOOPUCMFPS-ZLNGONTQSA-N (1s,3z)-3-[(2e)-2-[(1r,3as,7ar)-1-[(2r)-5-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCC(O)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C SNOXQOOPUCMFPS-ZLNGONTQSA-N 0.000 description 1
- FCKJYANJHNLEEP-SRLFHJKTSA-N 24,25-dihydroxycholecalciferol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCC(O)C(C)(C)O)C)=C\C=C1\C[C@@H](O)CCC1=C FCKJYANJHNLEEP-SRLFHJKTSA-N 0.000 description 1
- 239000004040 24-hydroxy-cholecalciferol Substances 0.000 description 1
- JWUBBDSIWDLEOM-UHFFFAOYSA-N 25-Hydroxycholecalciferol Natural products C1CCC2(C)C(C(CCCC(C)(C)O)C)CCC2C1=CC=C1CC(O)CCC1=C JWUBBDSIWDLEOM-UHFFFAOYSA-N 0.000 description 1
- 239000003872 25-hydroxy-cholecalciferol Substances 0.000 description 1
- IJNDMZIDDKVXHR-DYEHSFNOSA-N 5-[(2r)-2-[(1r,3as,4e,7ar)-4-[(2z)-2-[(5s)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-1-yl]propyl]-3-hydroxy-3-methyloxolan-2-one Chemical compound C([C@@H](C)[C@@H]1[C@]2(CCCC(/[C@@H]2CC1)=C\C=C\1C(CC[C@H](O)C/1)=C)C)C1CC(C)(O)C(=O)O1 IJNDMZIDDKVXHR-DYEHSFNOSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 208000006386 Bone Resorption Diseases 0.000 description 1
- 235000021318 Calcifediol Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 229930192627 Naphthoquinone Natural products 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 102000003982 Parathyroid hormone Human genes 0.000 description 1
- 108090000445 Parathyroid hormone Proteins 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241000485664 Protortonia cacti Species 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- 230000024279 bone resorption Effects 0.000 description 1
- 239000001058 brown pigment Substances 0.000 description 1
- JWUBBDSIWDLEOM-DTOXIADCSA-N calcidiol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)CCC1=C JWUBBDSIWDLEOM-DTOXIADCSA-N 0.000 description 1
- WMYIVSWWSRCZFA-DKRDSXHXSA-N calcitriol 26,23-lactone Chemical compound C([C@@H](C)[C@@H]1[C@]2(CCCC(/[C@@H]2CC1)=C\C=C\1C([C@@H](O)C[C@H](O)C/1)=C)C)C1CC(C)(O)C(=O)O1 WMYIVSWWSRCZFA-DKRDSXHXSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 150000002791 naphthoquinones Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 208000005368 osteomalacia Diseases 0.000 description 1
- 210000002990 parathyroid gland Anatomy 0.000 description 1
- 239000000199 parathyroid hormone Substances 0.000 description 1
- 229960001319 parathyroid hormone Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 230000000176 photostabilization Effects 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- BJYLYJCXYAMOFT-RSFVBTMBSA-N tacalcitol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CC[C@@H](O)C(C)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C BJYLYJCXYAMOFT-RSFVBTMBSA-N 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
<産業上の利用分野>
本発明は、活性成分である活性型ビタミンD3
類が安定化された活性型ビタミンD3類の軟カプ
セル剤に関する。更に詳しくは本発明は、現在活
性型として知られているビタミンD3の代謝産物
および合成類似化合物を活性成分とし、その皮膜
中に天然着色料を含有せしめた軟カプセル剤であ
つて、活性成分が光に対して安定化された活性型
ビタミンD3類の軟カプセル剤に関する。
<従来技術>
1α,25−ジヒドロキシコレカルシフエロール、
1α,24−ジヒドロキシコレカルシフエロール、
1α−ヒドロキシコレカルシフエロールなどの活
性型ビタミンD3類は、小腸でカルシウムの吸収、
運搬を促進し、骨で骨吸収、骨形成を調節し、副
甲状腺で副甲状腺ホルモンの分泌を抑制する作用
などを有するホルモンである。したがつて、活性
型ビタミンD3類が不足し、カルシウムの吸収が
低下している腎不全、骨軟化症に、あるいは骨代
謝異常疾患である骨粗鬆症に、または活性型ビタ
ミンD3類の不足を呈するくる病等の治療に活性
型ビタミンD3類は有効とされている。
しかし、これらの化合物はいずれも、熱、光に
対して不安定であり、酸化されやすい為、保存す
るときには、冷却、遮光、不活性気体による置換
などの手段をとることが望ましい。このことは、
これらを含有する製剤に於ても、同様であり、高
い保存安定性を確保する手段、とりわけ光に対す
る安定化手段を製剤に施すことが必要となる。
<発明が解決しようとする問題点>
従来、不安定な薬物を活性成分とする製剤の光
安定化方法としては、皮膜中に食用黄色4号等の
食用タール系色素を分散せしめて軟カプセル化す
る方法(特開昭55−22645号公報、特開昭58−
13511号公報)が知られている。しかるに最近、
食用タール系色素の安全性に疑問がもたれ問題と
されている。
一方、光安定化方法の別法として、皮膜中に天
然着色料であるカラメルを含有せしめて軟カプセ
ル化する方法(特開昭55−127448号公報)が知ら
れている。
しかしながら、カラメルは曝光されるとカラメ
ル自身が退色しその結果、活性成分である薬物の
光安定性が劣化するという欠点がある。
特開昭54−138119号公報には、カルミン酸、ラ
ツカイン酸、カカオ色素およびカルミン酸レーキ
から選ばれる天然色素を含有する安全で、かつ着
色の安定性良好なゼラチンカプセルが開示されて
いる。
しかしながら、これらの天然色素が活性型ビタ
ミンD3類の光安定化に有効であるか否かについ
ては明らかにされていない。
<問題点を解決するための手段>
本発明者らは、人体にとつて安全で、かつ活性
型ビタミンD3類が安定化された軟カプセル剤に
ついて鋭意研究した結果、カカオ色素、アピゲニ
ン、カルミン酸、カルミン酸レーキ、ラツカイン
酸、シコニンからなる群から選ばれた一種以上の
天然着色料を皮膜中に含有せしめた軟カプセル剤
が上記の目的を達成することを見出し本発明に到
達した。
すなわち、本発明は薬物として活性型ビタミン
D3類を含む軟カプセル剤であつて、その皮膜中
に、カカオ色素、アピゲニン、カルミン酸、カル
ミン酸レーキ、ラツカイン酸及びシコニン酸から
なる群より選ばれた一種もしくは二種以上の天然
着色料を含有する活性型ビタミンD3類の軟カプ
セル剤である。
本発明において用いられる活性型ビタミンD3
類としては、例えば、1α−ヒドロキシコレカル
シフエロール(1α−OH−D3)、1α,25−ジヒド
ロキシコレカルシフエロール(1α,25−(OH)2
−D3)、1α,24−ジヒドロキシコレカルシフエロ
ール(1α,24−(OH)2−D3)、1α,24,25−トリ
ヒドロキシコレカルシフエロール(1α,24,25
−(OH)3−D3)、1α−ヒドロキシ−24−オキソコ
レカルシフエロール、1α,25−ジヒドロキシ−
24−オキソコレカルシフエロール、1α,25−ジ
ヒドロキシコレカルシフエロール−26,23−ラク
トン、1α,25−ジヒドロキシコレカルシフエロ
ール−26,23−パーオキシラクトン、26,26,
26,27,27,27−ヘキサフルオロ−1α,25−ジ
ヒドロキシコレカルシフエロールなどの1α位に
水酸基を有する活性型ビタミンD3類;あるいは
25−ヒドロキシコレカルシフエロール(25−OH
−D3)、24−ヒドロキシコレカルシフエロール
(24−OH−D3)、24−オキソコレカルシフエロー
ル、24,25−ジヒドロキシコレカルシフエロール
(24,25−(OH)2−D3)、25−ヒドロキシ−24−
オキソコレカルシフエロール、25−ヒドロキシコ
レカルシフエロール26,23−ラクトン、25−ヒド
ロキシコレカルシフエロール−26,23−パーオキ
シラクトンなどの1α位に水酸基を有しない活性
型ビタミンD3類などが挙げられる。
本発明において用いられる天然着色料としては
カカオ色素、アピゲニン、カルミン酸、カルミン
酸レーキ、ラツカイン酸、シコニンがあげられ
る。カカオ色素はカカオ豆より得られる水溶性の
チヨコレート色色素であり、チヨコレート、ドロ
ツプ、アイスクリーム等に既に利用されている。
アピゲニンはコウリヤンより得られる褐色色素で
ある。カルミン酸は中南米に自生しているサボテ
ンに寄生する昆虫、エンジムシ(Coccus cacti)
の雌体の乾燥粉末から得られる赤色色素ノコチニ
ールの主成分であり、ジヤム等に使用されてい
る。カルミン酸レーキは上記カルミン酸をアルミ
ニウムまたはカルシウムレーキとしたものであ
る。ラツカイン酸はタイ、インドに産するラツク
カイガラ虫(Lacciter accakerr)の雌が分泌す
るスチツクラツクから得られる水溶性赤色色素で
カルミン酸と同様に使用されている。シコニンは
シコンより得られる赤紫のナフトキノン系色素で
口紅等に利用されている。
これらの天然着色料の内、一種を用いてもよい
し、二種以上を混合して用いてもよい。
これらの天然着色料の内、色調の一定性の点か
らカカオ色素、アピゲニンが好ましいが、若干の
色調の差が許容される場合はその限りではない。
通常使用される天然着色料の量は、軟カプセル
剤皮膜の2重量%以下、好ましくは0.01〜1重量
%である。
天然着色料は、皮膜中に均一に分散せしめるの
が好ましい。また天然着色料を、カプセル皮膜の
表面にのみ分散させてもよい。
軟カプセル皮膜は、通常使用されるゼラチン、
アラビアゴム、グリセリン、ソルビツトなどから
所望により選択された成分からなるものであり、
皮膜中には所望に応じて他の添加剤を加えてもよ
い。添加剤としては、例えばパラオキシ安息香酸
エステル、ベンジルアルコール、ソルビン酸など
の保存剤;グリセリン、プロピレングリコールな
どの可塑剤;タルク、酸化チタン、アルミナ、炭
酸カルシウムなどの着色剤が挙げられる。
活性型ビタミンD3類は通常、油性基剤に溶解
せしめて軟カプセル剤に含有するのが好ましい。
油性基剤としては、脂肪酸のグリセリド類、コ
ーンオイル、オリーブ油等の植物油等が挙げら
れ、常温で油状の脂肪油で活性型ビタミンD3類
の安定性を損わないものであれば、いずれでも使
用しうる。
本発明の軟カプセル剤は、天然着色料を含む軟
カプセルで、上記軟カプセルの内容物を、平板
法、ロータリ法、滴下法などの通常の方法によ
り、包み込むことによつて製造することができ
る。また軟化カプセルを糖衣用のパン、流動床な
どに入れ、天然着色料の水溶液をスプレーガンで
噴霧する方法によつても得ることができる。
<発明の効果>
本発明の軟カプセル剤によれば活性成分である
活性型ビタミンD3類が光安定化され、かつ人体
への安全性に問題がない、活性型ビタミンD3類
の軟カプセル剤が提供されるものであり、本発明
の意味は大きい。
<実施例>
以下に本発明を実施例により更に詳細に説明す
る。
実施例 1
1α−ヒドロキシコレカルシフエロールを脂肪
油(分画ココナツツ油)に溶解し、7μg/mlの
濃度の溶液を得、これに
カカオ色素(ポリアフエー(71)−台糖:台糖
(株)製)()、
アピゲニン(サンブラウンK:三栄化学(株)製)
()、
カルミン酸(粉末サンレツドNo.1:三栄化学(株)
製)()、
カルミン(東京化成(株)製)()、
ラツカイン酸(サンレツドLN:三栄化学(株)製
()、
を各々、0.45重量%含有する剤皮(ゼラチン100
重量部、グリセリン20重量部、パラオキシ安息香
酸エチル0.2重量部、パラオキシ安息香酸プロパ
ル0.2重量部、精製水80重量部)を施し、1α−ヒ
ドロキシコレカルシフエロールを1μg含有する
軟カプセルを得た。これらをカーボンアークウエ
ザーメーターにより10.5時間まで照射することに
より、加速曝光試験を行い、高速液体クロマトグ
ラフイーにより1α−ヒドロキシコレカルシフエ
ロール残存率を求めた。尚、何ら天然着色料を用
いない剤皮およびカラメル(FA:昭和化学工
業(株)()を用いた剤皮からなる軟カプセル剤を
比較のため同時に試験し、下記表の如き結果を得
た。
<Industrial Application Field> The present invention is directed to the use of active vitamin D 3 as an active ingredient.
The present invention relates to a soft capsule of active vitamin D type 3 stabilized by type 3. More specifically, the present invention is a soft capsule containing a metabolite of vitamin D3 currently known as an active form and a synthetic analogue compound as an active ingredient, and a natural coloring agent contained in the shell of the capsule. This invention relates to a soft capsule of active vitamin D type 3 , which is stabilized against light. <Prior art> 1α,25-dihydroxycholecalciferol,
1α,24-dihydroxycholecalciferol,
Active vitamin D 3 , such as 1α-hydroxycholecalciferol, helps in absorption of calcium in the small intestine,
It is a hormone that promotes transport, regulates bone resorption and bone formation in the bones, and suppresses the secretion of parathyroid hormone in the parathyroid glands. Therefore, the deficiency of active vitamin D type 3 can cause kidney failure and osteomalacia, where calcium absorption is reduced, or osteoporosis, which is a disease of abnormal bone metabolism, or deficiency of active vitamin D type 3 . Three active forms of vitamin D are said to be effective in treating conditions such as rickets. However, since all of these compounds are unstable to heat and light and easily oxidized, it is desirable to take measures such as cooling, shielding from light, and replacing with an inert gas when storing them. This means that
The same applies to formulations containing these, and it is necessary to provide the formulation with means to ensure high storage stability, especially means for stabilizing against light. <Problems to be solved by the invention> Conventionally, methods for photostabilizing formulations containing unstable drugs as active ingredients have involved dispersing food tar-based pigments such as Food Yellow No. 4 in a film to form soft capsules. Methods of
13511) is known. However, recently,
The safety of food tar-based dyes has been questioned and is becoming a problem. On the other hand, as an alternative to the photostabilization method, a method is known in which caramel, which is a natural coloring agent, is contained in the film to form a soft capsule (Japanese Patent Laid-Open Publication No. 127448/1982). However, caramel has the disadvantage that when exposed to light, the caramel itself discolors, and as a result, the photostability of the active ingredient drug deteriorates. JP-A-54-138119 discloses gelatin capsules containing a natural coloring selected from carminic acid, latsukaic acid, cacao pigment, and carminic acid lake, which is safe and has good coloring stability. However, it has not been clarified whether these natural pigments are effective in photostabilizing active vitamin D3 . <Means for Solving the Problems> As a result of intensive research into soft capsules that are safe for the human body and have stabilized active vitamin D 3 , the present inventors found that cacao pigment, apigenin, and carmine. The present invention was accomplished by discovering that a soft capsule containing one or more natural coloring agents selected from the group consisting of acid, carminic acid lake, latsukaic acid, and shikonin in the film achieves the above object. In other words, the present invention provides active vitamins as drugs.
A soft capsule containing D 3 , which contains one or more natural coloring agents selected from the group consisting of cacao pigment, apigenin, carminic acid, carminic acid lake, latcaic acid, and shichonic acid. This is a soft capsule containing active vitamin D type 3 . Active vitamin D 3 used in the present invention
Examples include 1α-hydroxycholecalciferol (1α-OH-D 3 ), 1α,25-dihydroxycholecalciferol (1α,25-(OH) 2
-D 3 ), 1α,24-dihydroxycholecalciferol (1α,24-(OH) 2 -D 3 ), 1α,24,25-trihydroxycholecalciferol (1α,24,25
-(OH) 3 -D 3 ), 1α-hydroxy-24-oxocholecalciferol, 1α,25-dihydroxy-
24-oxocholecalciferol, 1α,25-dihydroxycholecalciferol-26,23-lactone, 1α,25-dihydroxycholecalciferol-26,23-peroxylactone, 26,26,
Active vitamin D 3 having a hydroxyl group at the 1α position such as 26, 27, 27, 27-hexafluoro-1α, 25-dihydroxycholecalciferol; or
25-hydroxycholecalciferol (25-OH
-D3 ), 24-hydroxycholecalciferol (24-OH- D3 ), 24-oxocholecalciferol, 24,25-dihydroxycholecalciferol (24,25-(OH) 2 - D3) ), 25-hydroxy-24-
Active vitamin D 3 types that do not have a hydroxyl group at the 1α position, such as oxocholecalciferol, 25-hydroxycholecalciferol 26,23-lactone, and 25-hydroxycholecalciferol-26,23-peroxylactone, etc. can be mentioned. Natural coloring agents used in the present invention include cocoa pigment, apigenin, carminic acid, carminic acid lake, latukaic acid, and shikonin. Cocoa pigment is a water-soluble thiokolate color pigment obtained from cocoa beans, and is already used in thiokolate, drops, ice cream, etc.
Apigenin is a brown pigment obtained from Kouriyan. Carminic acid is extracted from Coccus cacti, a cactus-parasitic insect that grows naturally in Central and South America.
It is the main component of the red pigment nocochineal, which is obtained from the dried powder of the female body of the female body, and is used in jams, etc. Carminic acid lake is the above-mentioned carminic acid made into aluminum or calcium lake. Lactukaic acid is a water-soluble red pigment obtained from the scales secreted by females of the Lacciter accakerr, which is native to Thailand and India, and is used in the same way as carminic acid. Shikonin is a reddish-purple naphthoquinone pigment obtained from Shicon and is used in lipsticks and other products. Among these natural colorants, one type may be used, or two or more types may be used in combination. Among these natural colorants, cacao pigment and apigenin are preferred from the viewpoint of consistency of color tone, but this is not the case if a slight difference in color tone is acceptable. The amount of natural colorants commonly used is up to 2% by weight of the soft capsule coating, preferably from 0.01 to 1%. Preferably, the natural colorant is uniformly dispersed in the film. Alternatively, the natural colorant may be dispersed only on the surface of the capsule membrane. The soft capsule membrane is made of commonly used gelatin,
It consists of ingredients selected from gum arabic, glycerin, sorbitol, etc.
Other additives may be added to the film as desired. Examples of additives include preservatives such as paraoxybenzoate, benzyl alcohol, and sorbic acid; plasticizers such as glycerin and propylene glycol; and colorants such as talc, titanium oxide, alumina, and calcium carbonate. It is usually preferable that active vitamin D 3 is dissolved in an oily base and contained in a soft capsule. Examples of oily bases include fatty acid glycerides, corn oil, vegetable oils such as olive oil, etc. Any fatty oil that is oily at room temperature and does not impair the stability of active vitamin D 3 can be used. Can be used. The soft capsule of the present invention is a soft capsule containing a natural coloring agent, and can be produced by wrapping the contents of the soft capsule by a conventional method such as a plate method, a rotary method, or a dropping method. . It can also be obtained by placing softened capsules in a sugar-coating pan, fluidized bed, etc., and spraying an aqueous solution of a natural coloring agent with a spray gun. <Effects of the Invention> According to the soft capsule of the present invention, active vitamin D type 3 , which is an active ingredient, is photostabilized, and there are no safety problems for the human body, and the soft capsule contains active vitamin D type 3 . The present invention has great significance. <Examples> The present invention will be explained in more detail below using examples. Example 1 1α-Hydroxycholecalciferol was dissolved in fatty oil (fractionated coconut oil) to obtain a solution with a concentration of 7 μg/ml, and this was mixed with cocoa pigment (polyphae(71)-standose: standose sugar).
Co., Ltd.) (), Apigenin (Sun Brown K: Sanei Chemical Co., Ltd.)
(), Carminic acid (Powder Sunretsu No. 1: Sanei Chemical Co., Ltd.)
A shell containing 0.45% by weight of carmine (manufactured by Tokyo Kasei Co., Ltd.) (), latsukaic acid (Sunretsudo LN: manufactured by Sanei Chemical Co., Ltd.) (), and 0.45% by weight (gelatin 100
20 parts by weight of glycerin, 0.2 parts by weight of ethyl paraoxybenzoate, 0.2 parts by weight of propal paraoxybenzoate, and 80 parts by weight of purified water) to obtain soft capsules containing 1 μg of 1α-hydroxycholecalciferol. An accelerated light exposure test was performed by irradiating these for up to 10.5 hours with a carbon arc weather meter, and the residual rate of 1α-hydroxycholecalciferol was determined by high performance liquid chromatography. For comparison, soft capsules consisting of a shell without any natural coloring agent and a shell using caramel (FA: Showa Kagaku Kogyo Co., Ltd.) were tested at the same time, and the results shown in the table below were obtained. .
【表】
実施例 2
実施例1における1α−ヒドロキシコレカルシ
フエロールの代りに、1α,24−ジヒドロキシコ
レカルシフエロールを用いる以外は実施例1と同
様に実施し、下記表の如き結果を得た。[Table] Example 2 The same procedure as in Example 1 was carried out except that 1α,24-dihydroxycholecalciferol was used instead of 1α-hydroxycholecalciferol in Example 1, and the results shown in the table below were obtained. Ta.
【表】【table】
【表】
実施例 3
1α−ヒドロキシコレカルシフエロールを分画
ココナツツ油に溶解し7μg/mlの濃度の油性溶
液を得た。ゼラチン100重量部、グリセリン20重
量部、パラオキシ安息香酸エチル0.2重量部、パ
ラオキシ安息香酸プロピル0.2重量部、カカオ色
素0.5重量部および精製水80重量部から成る剤皮
成分を加温溶解して被覆剤とし、1カプセルにつ
き1α−ヒドロキシコレカルシフエロールが1μg
含有するように連続式軟カプセル製造機を用いて
剤皮を施して軟カプセル剤を製造した。[Table] Example 3 1α-hydroxycholecalciferol was dissolved in fractionated coconut oil to obtain an oily solution with a concentration of 7 μg/ml. A coating agent is prepared by heating and dissolving shell components consisting of 100 parts by weight of gelatin, 20 parts by weight of glycerin, 0.2 parts by weight of ethyl paraoxybenzoate, 0.2 parts by weight of propyl parahydroxybenzoate, 0.5 parts by weight of cacao pigment, and 80 parts by weight of purified water. and 1μg of 1α-hydroxycholecalciferol per capsule.
A continuous soft capsule making machine was used to apply a shell to produce soft capsules containing the following ingredients.
Claims (1)
プセル剤であつて、その皮膜中に、カカオ色素、
アピゲニン、カルミン酸、カルミン酸レーキ、ラ
ツカイン酸及びシコニンからなる群から選ばれた
一種もしくは二種以上の天然着色料を含有する活
性型ビタミンD3類の軟カプセル剤。1 A soft capsule containing active vitamin D type 3 as a drug, which contains cacao pigment,
A soft capsule of active vitamin D type 3 containing one or more natural colorants selected from the group consisting of apigenin, carminic acid, carminic acid lake, latukaic acid, and shikonin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP19322185A JPS6253923A (en) | 1985-09-03 | 1985-09-03 | Soft capsule agent of activated vitamin d3 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP19322185A JPS6253923A (en) | 1985-09-03 | 1985-09-03 | Soft capsule agent of activated vitamin d3 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6253923A JPS6253923A (en) | 1987-03-09 |
JPH0327535B2 true JPH0327535B2 (en) | 1991-04-16 |
Family
ID=16304327
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP19322185A Granted JPS6253923A (en) | 1985-09-03 | 1985-09-03 | Soft capsule agent of activated vitamin d3 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6253923A (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2696271B2 (en) * | 1990-11-26 | 1998-01-14 | 日本エランコ株式会社 | Hard gelatin capsule |
US5972995A (en) * | 1997-10-16 | 1999-10-26 | Children's Hospital Medical Center Of Northern California | Compositions and methods for cystic fibrosis therapy |
FR2814369B1 (en) * | 2000-09-27 | 2004-05-21 | Spmd | DRUG VITAMIN D3 PREPARATION AND PROCESS FOR PRODUCING THE SAME |
JP3549522B1 (en) * | 2003-10-24 | 2004-08-04 | 日清ファルマ株式会社 | Coenzyme Q10-containing capsule |
JP2020183346A (en) * | 2019-04-26 | 2020-11-12 | ロート製薬株式会社 | Oral composition |
-
1985
- 1985-09-03 JP JP19322185A patent/JPS6253923A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS6253923A (en) | 1987-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2304432C2 (en) | Preparation for decreasing fatigue | |
US6441050B1 (en) | Palatable oral coenzyme Q liquid | |
EP1575378A1 (en) | Pulverulent phytosterol formulations | |
US6197813B1 (en) | Stable liquid mineral ascorbate compositions and methods of manufacture and use | |
JPWO2006035900A1 (en) | Coenzyme Q10-containing emulsion composition | |
EP0116755A1 (en) | Composition for solid pharmaceutical preparations of active vitamins D3 and process for preparation thereof | |
KR20020031333A (en) | Soft capsules | |
JP2003119127A (en) | Stable preparation of reduced coenzyme q | |
IE902529A1 (en) | Antiseptic compositions containing¹hexahydro-5-pyrimidinamine compounds and an amphoteric¹surfactant and methods for preparing same | |
JPWO2008029909A1 (en) | Composition containing reduced coenzyme Q10 and lysolecithin | |
JPH092947A (en) | Therapeutic agent for hypercholesterolemia | |
JP4627816B2 (en) | Lip balm | |
JPH0327535B2 (en) | ||
JPH0244806B2 (en) | BITAMINAOANTEINIHAIGOSHITANYUKAKEIHIFUGAIYOZAISOSEIBUTSU | |
SK121699A3 (en) | Stable solid preparation containing vitamin d3 and tricalcium phosphate | |
JPH04288016A (en) | Production of soft capsule agent of active type vitamin d3s | |
JP2002204673A (en) | Solid preparation having multicore structure | |
JPH0899872A (en) | Production of stable carotenoid pharmaceutical preparation without malodor | |
JP2002348228A (en) | Ascorbic acid-containing composition for outer skin | |
US5504105A (en) | Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use | |
IE57070B1 (en) | Foodstuffs,including chewing gum with anti-caries activity,and processes for preparing them | |
JP2007284456A (en) | Lip cream | |
JP2003231628A (en) | Lip cream | |
KR100943652B1 (en) | Composition comprising coenzyme Q10 with enhanced bioavailability | |
JPS61225257A (en) | Flavin-base natural coloring matter containing composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |